Blood lead concentrations in children with iron deficiency anemia: a systematic review and meta-analysis

Tahere Farkhondeh1, Borhan Mansouri2, Lukasz J Binkowski3

  • 1Medical Toxicology and Drug Abuse Research Center (MTDRC), Birjand University of Medical Sciences, Birjand, Iran.

Insights

Iron deficiency anemia (IDA) in children is linked to higher blood lead levels (BLL). This meta-analysis found IDA children had significantly higher BLL, increasing their risk of lead exposure.

Area of Science:

  • Pediatric Nutrition
  • Environmental Health
  • Toxicology

Background:

  • Iron deficiency anemia (IDA) is a prevalent nutritional disorder impacting children's development.
  • IDA may increase children's susceptibility to toxic metals like lead (Pb).
  • The relationship between IDA and blood lead levels (BLL) in children requires further clarification.

Purpose of the Study:

  • To conduct a systematic review and meta-analysis of the association between IDA and BLL in children.
  • To synthesize existing evidence on the link between iron status and lead exposure in pediatric populations.

Main Methods:

  • Literature search of international databases (ISI Web of Science, PubMed, Scopus) up to September 2021.
  • Inclusion of 12 studies meeting specific criteria, assessed using the Newcastle-Ottawa Scale (NOS).
  • Meta-analysis performed using R statistical software with the 'meta' package.

Main Results:

  • Children with IDA exhibited significantly higher blood lead levels (SMD = 2.40, p = 0.0014).
  • A pooled odds ratio (OR) of 2.75 (p = 0.0303) suggests an increased risk of IDA in children with BLL > 10 µg/dL.
  • The meta-analysis identified a significant positive association between IDA and elevated BLL in children.

Conclusions:

  • A significant association exists between iron deficiency anemia and higher blood lead levels in children.
  • Systematic monitoring of iron and lead levels is recommended for children, especially in food-insecure regions.
  • Further research is needed due to the limited number of studies included in this meta-analysis.

Related Concept Videos

The Periodic Table and Organismal Elements00:57

The Periodic Table and Organismal Elements

Overview
191.4K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
23
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
1.4K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
27
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
32
Overview of Hematopoiesis01:20

Overview of Hematopoiesis

Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
5.4K